search
Back to results

HMP for Addictions Study

Primary Purpose

Opioid Use Disorder, Opioid Use, Buprenorphine Dependence

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Healthy Minds Program for Addictions
Sponsored by
University of Wisconsin, Madison
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Opioid Use Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Individuals at least 18 years of age English-speaking Veterans Ability to understand and willingness to sign a written informed consent document Have access to a smartphone, tablet, or computer with internet connection to access recordings for home practice Ability and willingness to attend all 6 session of the study, and to complete all assessment questionnaires Verified Post-Traumatic Stress Disorder (PTSD) according to DSM-5 criteria On buprenorphine maintenance treatment for OUD for a minimum of 3 months Exclusion Criteria: Regular daily meditation practice for past 6 months or regular weekly meditation practice for past 12 months Attended a meditation retreat or a yoga/body practice retreat with a significant meditation component Previous use of Healthy Minds Program app Current suicidal intent and/or high self-injury risk, as determined from the interview Current psychopathology that interferes with study participation as assessed by interview

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    6 weeks of sessions

    Arm Description

    Participants will be asked to attend 6 2-hour weekly in-person sessions

    Outcomes

    Primary Outcome Measures

    Retention in treatment
    Number of participants who complete all 6 sessions, as measured through actual attendance.
    Change in predictors of relapse and recovery
    The Brief Addiction Monitor (BAM) is a 17-item, multidimensional, progress-monitoring instrument for patients in treatment for a substance use disorder (SUD). The BAM includes items that assess risk factors for substance use (scores 0-24, higher scores meaning more risk), protective factors that support sobriety (scores 0-24, higher scores meaning more protection), and drug and alcohol use (scores 0-12, higher scores meaning more use). The BAM produces composite scores for the three aforementioned domains.

    Secondary Outcome Measures

    Change in psychological distress - perceived stress
    Stress will be measured using the 10-item NIH Perceived Stress Scale. Each question is scored from 0 (never) to 5 (very often). The total score ranges from 0 to 40, with higher scores indicating higher levels of stress.
    Change in psychological distress - anxiety and depression
    Anxiety and depression will be measured using the Patient Reported Outcomes Measurement Information Systems (PROMIS) Anxiety and Depression scales. The investigators will use the computer adaptive version of both measures which have a mean of 50 and a standard deviation of 10. A composite will be computed by average across T-scores. T-scores range from 10 to 90 with higher scores indicating higher depression or anxiety.
    Change in PTSD symptoms
    PTSD symptoms will be measured by the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (PCL-5). The PCL-5 uses a 5-point Likert scale ranging from 0-4 for each symptom. Respondents rate how bothered they have been by each item in the past month. The items are summed to provide a total severity score ranging from 0-80. Higher scores indicate a higher level of symptoms.
    Change in well-being
    Well-being will be measured using the 17-item Healthy Minds Index (HMI). The HMI assesses qualities trained in the HMP app (awareness, connection, insight, purpose). It is scored on a 0- to 4-point Likert scale where 0 = a low amount (e.g., never, not at all, none of the time) and 4 = a higher amount (e.g., always, to the highest degree, all of the time) of a particular quality.

    Full Information

    First Posted
    September 20, 2023
    Last Updated
    September 27, 2023
    Sponsor
    University of Wisconsin, Madison
    Collaborators
    Center for Healthy Minds
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06063499
    Brief Title
    HMP for Addictions Study
    Official Title
    Healthy Minds Program for Veterans With Opioid Use Disorder on Buprenorphine Maintenance Treatment: A Pilot Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    January 2024 (Anticipated)
    Primary Completion Date
    April 2024 (Anticipated)
    Study Completion Date
    April 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University of Wisconsin, Madison
    Collaborators
    Center for Healthy Minds

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The goal of this clinical trial is to see whether the Healthy Minds Program for Addictions could be used to help veterans with moderate-sever opioid use disorder and post-traumatic stress disorder stay on buprenorphine maintenance treatment. Participants will be asked to complete a six-week program consisting of 6 weekly, 2-hour in-person group sessions, as well as assessments before the start of the sessions.
    Detailed Description
    This is a 6-week, single-arm, single-center pilot study of the acceptability and efficacy of an adaptation of the Healthy Minds Program for Veterans with opioid use disorder on buprenorphine maintenance treatment. Following the Screening Visit, eligible subjects will complete 6 in-person sessions over the course of 2 months. The first session will be an introductory session introducing the basics of the program. After the introductory session, there will be four weekly sessions, each dedicated to a different domain of the program - awareness, connection, insight, and purpose. Participants will be encouraged to practice daily anywhere from 5 to 30 minutes from a set of practices that will be available to them on a password protected website. The intervention will end with a closing session where participants will have the opportunity to reflect on their experience of the program and share feedback. Weekly sessions will be held in person and will be facilitated by an MD, PhD Psychiatrist and Neuroscientist with 8 years of mindfulness practice together with a certified Peer Support Specialist.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Opioid Use Disorder, Opioid Use, Buprenorphine Dependence

    7. Study Design

    Primary Purpose
    Basic Science
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    12 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    6 weeks of sessions
    Arm Type
    Experimental
    Arm Description
    Participants will be asked to attend 6 2-hour weekly in-person sessions
    Intervention Type
    Behavioral
    Intervention Name(s)
    Healthy Minds Program for Addictions
    Intervention Description
    The Healthy Minds Program for Addictions is a 6-week, hybrid version of the original Healthy Minds Program (HMP), in which all lessons are adapted from the original lessons available in the app and delivered exclusively in person over weekly group sessions. The HMP has >100 guided audio practices that address 4 constituents of wellbeing: awareness, connection, insight, and purpose. Study participants will have access to specific practices from the HMP that are particularly relevant to the needs of populations with substance use disorders and trauma.
    Primary Outcome Measure Information:
    Title
    Retention in treatment
    Description
    Number of participants who complete all 6 sessions, as measured through actual attendance.
    Time Frame
    Through study completion, up to 4 months
    Title
    Change in predictors of relapse and recovery
    Description
    The Brief Addiction Monitor (BAM) is a 17-item, multidimensional, progress-monitoring instrument for patients in treatment for a substance use disorder (SUD). The BAM includes items that assess risk factors for substance use (scores 0-24, higher scores meaning more risk), protective factors that support sobriety (scores 0-24, higher scores meaning more protection), and drug and alcohol use (scores 0-12, higher scores meaning more use). The BAM produces composite scores for the three aforementioned domains.
    Time Frame
    Baseline, 3 weeks, 6 weeks
    Secondary Outcome Measure Information:
    Title
    Change in psychological distress - perceived stress
    Description
    Stress will be measured using the 10-item NIH Perceived Stress Scale. Each question is scored from 0 (never) to 5 (very often). The total score ranges from 0 to 40, with higher scores indicating higher levels of stress.
    Time Frame
    Baseline, 3 weeks, 6 weeks
    Title
    Change in psychological distress - anxiety and depression
    Description
    Anxiety and depression will be measured using the Patient Reported Outcomes Measurement Information Systems (PROMIS) Anxiety and Depression scales. The investigators will use the computer adaptive version of both measures which have a mean of 50 and a standard deviation of 10. A composite will be computed by average across T-scores. T-scores range from 10 to 90 with higher scores indicating higher depression or anxiety.
    Time Frame
    Baseline, 3 weeks, 6 weeks
    Title
    Change in PTSD symptoms
    Description
    PTSD symptoms will be measured by the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (PCL-5). The PCL-5 uses a 5-point Likert scale ranging from 0-4 for each symptom. Respondents rate how bothered they have been by each item in the past month. The items are summed to provide a total severity score ranging from 0-80. Higher scores indicate a higher level of symptoms.
    Time Frame
    Baseline, 3 weeks, 6 weeks
    Title
    Change in well-being
    Description
    Well-being will be measured using the 17-item Healthy Minds Index (HMI). The HMI assesses qualities trained in the HMP app (awareness, connection, insight, purpose). It is scored on a 0- to 4-point Likert scale where 0 = a low amount (e.g., never, not at all, none of the time) and 4 = a higher amount (e.g., always, to the highest degree, all of the time) of a particular quality.
    Time Frame
    Baseline, 3 weeks, 6 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Individuals at least 18 years of age English-speaking Veterans Ability to understand and willingness to sign a written informed consent document Have access to a smartphone, tablet, or computer with internet connection to access recordings for home practice Ability and willingness to attend all 6 session of the study, and to complete all assessment questionnaires Verified Post-Traumatic Stress Disorder (PTSD) according to DSM-5 criteria On buprenorphine maintenance treatment for OUD for a minimum of 3 months Exclusion Criteria: Regular daily meditation practice for past 6 months or regular weekly meditation practice for past 12 months Attended a meditation retreat or a yoga/body practice retreat with a significant meditation component Previous use of Healthy Minds Program app Current suicidal intent and/or high self-injury risk, as determined from the interview Current psychopathology that interferes with study participation as assessed by interview
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Virginia Medinilla
    Phone
    608-282-8270
    Email
    medinilla@wisc.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Timothy Juergens, MD
    Organizational Affiliation
    University of Wisconsin, Madison
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    HMP for Addictions Study

    We'll reach out to this number within 24 hrs